The ASX limped into the close on Friday, in a fairly tame finish to a roller-coaster week.

Evergrande contagion fears and jitters ahead of the US Fed meeting sparked a sharp selloff on Monday.

But a week (or three days) is a long time in markets, and by Thursday the prospect of both tighter monetary policy and/or a systemic Chinese property collapse posed little fear for investors.

After US stocks posted more strong gains on Thursday night, the good vibes were expected to flow through to the ASX this morning, but investors tapped the brakes as the ASX 200 finished around 0.4% lower.

While key sectors struggled for traction on Friday, energy was once again the trade that paid as oil & gas plays continue to benefit from consistent strength in benchmark oil prices.

TODAY’S BIGGEST WINNERS

Scroll or swipe to reveal table. Click headings to sort.

Great Boulder Resources (ASX:GBR) has some news to share, and investors will have to wait until Tuesday (at the latest) to find out what it is.

Shares in the WA-based gold and base metals explorer ripped higher in afternoon trade before going into a trading halt, pending a further announcement.

Early standout PepinNini Minerals (ASX:PNN) also held its gains, after striking a deal with Chinese (lithium) producer Ganfeng to run a pipeline through Pepinnini’s (copper-gold) project in Argentina.

Elsewhere, junior explorer FirstAU (ASX:FAU) rounded out a volatile week of trade with another strong gain, as it gets ready to kick off a 1,500m diamond drilling program at its ‘Snowstorm’ gold project in Victoria.

TODAY’S BIGGEST LOSERS

ANNOUNCEMENTS YOU MAY’VE MISSED

Scroll or swipe to reveal table. Click headings to sort.

Vita Group (ASX:VTG) entered into an agreement to sell its ICT business to Telstra (ASX:TLS). The deal will net the company $110 million of which $35 million will be retained to invest in its Artisan Aesthetic Clinics business with the balance to be returned to shareholders as a special dividend.
Brookside Energy (ASX:BRK) reported its Jewell well in the Anadarko Basin exceeded its pre-drill estimates amidst early flow-back testing. The well produced a daily production rate of 1,238 barrels of oil equivalent per day.
Paradigm Biopharmaceuticals (ASX:PAR) received ethics approval for its Phase 3 clinical trial in participants with knee osteoarthritis pain. The company will begin patient recruitment in the last quarter and has identified 8 sites across 5 states to conduct the Australian arm of the study.
Senex Energy (ASX:SXY) announced a gas sales agreement to supply 29Metals’ (ASX:29M) Capricorn copper mine. The deal will begin on January 1 next year and provides for 2.5 petajoules of natural gas.
Adherium (ASX:ADR)  was awarded a contract to supply its Hailie solution to an upcoming clinical study run by AstraZeneca in the US. It will provide a bespoke version of its Hailie sensor to track the usage of the investigational inhaler medications via patients’ phones.
Parkd (ASX:PKD) was awarded a construction contract to construct a 1900 square metre mezzanine level car park in Victor Park WA. The contract will provide for $1.5 million over the next 6 months.

TRADING HALTS

Monday

Silex Systems (ASX:SLX) – capital raising
High Peak Royalties (ASX:HPR) – capital raising
Armour Energy (ASX:AJQ) – capital raising
Sandfire Resources (ASX:SFR) – capital raising and acquisition
Engage:BDR (ASX:EN1) – capital raising
DC Two (ASX:DC2) – capital raising
Centuria Industrial REIT (ASX:CIP) – acquisitions and capital raising

Tuesday

92 Energy (ASX:92E) – capital raising
Eagle Mountain Mining (ASX:EM2) – capital raising
Invex Therapeutics (ASX:IXC) – manufacturing and supply agreement
Cannindah Resources (ASX:CAE) – drilling results
Tesserent (ASX:TNT) – capital raising
Great Boulder Resources (ASX:GBR) – price query